Relfydess® ▼ (RelabotulinumtoxinA) is the first and only ready-to-use liquid neuromodulator created with PEARLTM Technology, developed and manufactured by Galderma.

Relfydess® is a prescription only medicine indicated for the temporary improvement in the appearance of moderate to severe glabellar lines and lateral canthal lines in adult patients under 65 years.

The primary pharmacodynamic effect of Botulinum toxin type A is a chemical denervation of the treated muscle, resulting in a measurable decrease of the compound muscle action potential. This causes a localized reduction of muscle activity. When injected intramuscularly, the toxin induces paralysis of the affected muscle which temporarily reduces muscle activity.

Requires fridge storage between 2 and 8 degrees.

Keep vials in the outer carton in order to protect from light.

Patient Information Leaflet: https://www.medicines.org.uk/emc/files/pil.100710.pdf